Diagnostics (Oct 2022)

Clinical Application of Cardiac Magnetic Resonance in ART-Treated AIDS Males with Short Disease Duration

  • Keke Hou,
  • Hang Fu,
  • Wei Xiong,
  • Yueqin Gao,
  • Liqiu Xie,
  • Jianglin He,
  • Xianbiao Feng,
  • Tao Zeng,
  • Lin Cai,
  • Lei Xiong,
  • Nan Jiang,
  • Min Jiang,
  • Bin Kang,
  • Haiyan Zheng,
  • Na Zhang,
  • Yingkun Guo

DOI
https://doi.org/10.3390/diagnostics12102417
Journal volume & issue
Vol. 12, no. 10
p. 2417

Abstract

Read online

Cardiac complications are common in antiretroviral therapy-treated (ART-treated) acquired immune deficiency syndrome (AIDS) patients, and the incidence increases with age. Myocardial injury in ART-treated AIDS patients with a relatively longer disease duration has been evaluated. However, there is no relevant study on whether patients with a short AIDS duration have cardiac dysfunction. Thirty-seven ART-treated males with AIDS and eighteen healthy controls (HCs) were prospectively included for CMR scanning. Clinical data and laboratory examination results were collected. The ART-treated males with AIDS did not have significantly reduced biventricular ejection fraction, myocardial edema, or late gadolinium enhancement. Compared with the HCs, the biventricular volume parameters and left ventricle myocardial strain indices in ART-treated males with AIDS were not significantly reduced (all p > 0.05). ART-treated males with AIDS were divided into subgroups according to their CD4+ T-cell counts (p > 0.05). In Pearson correlation analysis, CD4+ T-cell counts were not significantly correlated with biventricular volume parameters or left ventricular myocardial strain indices. In conclusion, ART-treated males with AIDS receiving ART therapy with a short disease duration (less than 3 years) might not develop obvious cardiac dysfunction as evaluated by routine CMR, so it is reasonable to appropriately extend the interval between cardiovascular follow-ups to more than 3 years.

Keywords